MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
STOK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Stoke Therapeutics (STOK) Ownership - Who owns Stoke Therapeutics?

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
170
Web
https://www.stoketherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.87B
P/E Ratio
48.34
Total Cash
343.55M
Projected Growth
N/A
Total Debt
2.43M
Revenue
32.08M
Risk (Beta)
2.16
Dividend Yield
N/A
Total Cash/Share
5.52
Total Debt/Equity
N/A
Revenue/Share
0.53 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
STOK
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for STOK
A.I. Advisor
published General Information

General Information

a company, which engages in the research and development of treatments for genetic diseases.

Industry Biotechnology

Profile
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
170
Web
https://www.stoketherapeutics.com